MDSPX
Price
$34.34
Change
-$0.04 (-0.12%)
Updated
Jul 31 closing price
Net Assets
972.01M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MDSPX vs VSMAX

MDSPX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
MDSPX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDSPX is a Buy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. MDSPX (972M). VSMAX pays higher dividends than MDSPX: VSMAX (1.21) vs MDSPX (0.39). MDSPX was incepted earlier than VSMAX: MDSPX (32 years) vs VSMAX (26 years). MDSPX (1.03) is less costly to investors than VSMAX (0.05). MDSPX is a more actively managed with annual turnover of: 90.00 vs. VSMAX (17.00). MDSPX has a lower initial minimum investment than VSMAX: MDSPX (1000) vs VSMAX (3000). MDSPX annual gain was more profitable for investors over the last year : 27.90 vs. VSMAX (22.58). VSMAX (35.11) and MDSPX (34.55) have equivalent 5 years return.
MDSPXVSMAXMDSPX / VSMAX
Total Expense Ratio0.730.051,460%
Annual Report Gross Expense Ratio1.030.052,060%
Fund Existence32 years26 years-
Gain YTD18.78914.588129%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets972M189B1%
Annual Yield % from dividends0.391.2132%
Returns for 1 year27.9022.58124%
Returns for 3 years47.4943.42109%
Returns for 5 years34.5535.1198%
Returns for 10 years21.90155.9614%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H